Inherent Biosciences

company

About

Inherent Biosciences is a molecular diagnostics company that revolutionizes trial and error medicine and restore hope.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$255.95K
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Inherent Biosciences is a molecular diagnostics company that revolutionizes trial and error medicine and restore hope. The company does this by discovering what's inherent in our biology about the unexplained and translating discoveries into personal insights that inform actions.

Inherent Biosciences develops medicines for treating pain, infertility, embryo quality, autism, rheumatoid arthritis, psoriatic arthritis, fetal heart disease, COVID-19, and many more.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$255.95K
Inherent Biosciences has raised a total of $255.95K in funding over 2 rounds. Their latest funding was raised on Feb 17, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 17, 2021 Seed 2 Morning Star Foundation Detail
Sep 9, 2020 Grant $255.95K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
3
Inherent Biosciences is funded by 3 investors. Morning Star Foundation and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
Morning Star Foundation Yes Seed
National Science Foundation Yes Grant
Park City Angels Seed